M&A Deal Summary

Oncodesign Services Acquires ZoBio

On January 23, 2024, Oncodesign Services acquired life science company ZoBio

Acquisition Highlights
  • This is Oncodesign Services’ 1st transaction in the Life Science sector.
  • This is Oncodesign Services’ 1st transaction in France.

M&A Deal Summary

Date 2024-01-23
Target ZoBio
Sector Life Science
Buyer(s) Oncodesign Services
Deal Type Add-on Acquisition

Target

ZoBio

Leiden, France
ZoBio provides a complete solution for Fragment Based Drug Discovery to our clients. ZoBio is based in Leiden, France.

Search 214,503 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Oncodesign Services

Dijon, France

Category Company
Sector Life Science
Employees230
DESCRIPTION

Oncodesign Services is specialized in drug discovery and preclinical services. It contributes to the development of innovative therapies in oncology, inflammation and infectious diseases, through integrated capabilities in medicinal chemistry, DMPK, pharmaco-imaging, bioanalysis, and in vivo/in vitro pharmacology. Oncodesign Services is a based in Dijon, France.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: France M&A 1 of 1
Year: 2024 M&A 1 of 1